The European Medicines Agency (EMA) and the European Commission have published additional information material on biosimilar medicines, as part of their ongoing collaboration to improve understanding of biosimilars across the European Union (EU). A biosimilar is biological Medicine that is highly similar in all essential aspects to a 'reference' biological medicine already authorised.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
